✦ LIBER ✦

Prostate-specific antigen doubling time in the identification of patients at risk for progression after treatment and biochemical recurrence for prostate cancer

✍ Scribed by Glenn M Cannon Jr; Patrick C Walsh; Alan W Partin; Charles R Pound

Book ID: 116943867
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 147 KB
Volume: 62
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2003.09.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

UP-2.128: The Value of Prostate-Specific

UP-2.128: The Value of Prostate-Specific Antigen Doubling Time for Patients with Prostate Cancer After Maximal Androgen Blockade

✍ W. Wang; G. Shi; J. He; R. Zhou 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Presalvage prostate-specific antigen (PS

Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy

✍ Philippe E. Spiess; Andrew K. Lee; Dan Leibovici; Xuemei Wang; Kim-Anh Do; Louis 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

Prostate-specific antigen screening for

Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation : Analysis of trends over time

✍ Emil Scosyrev; Guan Wu; Supriya Mohile; Edward M. Messing 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

Re: Prostate-specific Antigen Screening

Re: Prostate-specific Antigen Screening for Prostate Cancer and the Risk of Overt Metastatic Disease at Presentation: Analysis of Trends Over Time

✍ William J. Catalona 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Evaluation of [11C]-choline positron-emi

Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer

✍ Ludwig Rinnab; Felix M. Mottaghy; Norbert M. Blumstein; Sven N. Reske; Richard E 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB

Comparative analysis of prostate-specifi

Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group

✍ Peter Grimm; Ignace Billiet; David Bostwick; Adam P. Dicker; Steven Frank; Jos I 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB